NCT03078907 – A Multi-center, Double-blind, Placebo-controlled Phase 4 Study in Patients With Pulmonary Arterial Hypertension to Assess the Effect of Selexipag on Daily Life Physical Activity and Patient’s Self-reported Symptoms and Their Impacts Posted on August 5, 2023 by tsuperadmin -
NCT02260557 – A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel Group, Exploratory Phase 2 Study to Assess Efficacy and Safety of Selexipag in Adult Subjects With Raynaud’s Phenomenon Secondary to Systemic Sclerosis Posted on January 28, 2020 by tsuperadmin -
NCT02471183 – Multicenter, Open-label, Single-group Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Adult Patients With Pulmonary Arterial Hypertension Posted on January 28, 2020 by tsuperadmin -
A clinical evaluation of the effect of maintaining haemoglobin levels with weekly EPREX®/ERYPO® (Epoetin alfa) in subjects with lymphoid malignancies (Hodgkin’s Disease, Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma) undergoing chemotherapy Posted on May 21, 2019 by tsuperadmin -
NCT00211120 – Correction of Hemoglobin and Outcomes In Renal Insufficiency (CHOIR) Posted on April 25, 2019 by tsuperadmin -
NCT01106014 – A Multicenter, Double-blind, Placebo-controlled Phase 3 Study Assessing the Safety and Efficacy of Selexipag on Morbidity and Mortality in Patients With Pulmonary Arterial Hypertension Posted on October 23, 2018 by tsuperadmin -
NCT00211146 – An Open-Label, Randomized, Parallel-Group Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Subjects Undergoing Major Elective Spinal Surgery Posted on January 23, 2018 by tsuperadmin -
NCT01394991 – A Randomized, Open-Label, Multicenter Study Evaluating Thrombovascular Events in Subjects With Cancer Receiving Chemotherapy and Administered Epoetin Alfa Once or Three Times a Week for the Treatment of Anemia Posted on January 23, 2018 by tsuperadmin -
NCT00266617 – The Effect of Subcutaneous r-HuEPO in Patients With Chronic Anemia Secondary to Chemotherapy Posted on November 10, 2017 by tsuperadmin -
NCT00269997 – The Effect of Subcutaneous r-HuEPO in Patients With Chronic Anemia Secondary to Cisplatin Chemotherapy Posted on November 10, 2017 by tsuperadmin -
The YODA Project